Literature DB >> 23402467

Vascular medicine: aortic and peripheral arterial disease.

Fadi Elias Shamoun1, Grant T Fankhauser, Martina Mookadam.   

Abstract

The medical management of patients with an abdominal aortic aneurysm (AAA) includes modification of risk factors, smoking cessation, cardiovascular risk treatment, and hypertensive therapy. No specific therapy has been shown to alter disease outcome. Many AAA and thoracic aortic aneurysms are amenable to endovascular treatment. Endovascular repair offers the benefit of shorter hospital stays and lower perioperative morbidity and mortality. Most patients with peripheral arterial disease (PAD) are asymptomatic or have atypical symptoms; only a few present with classic intermittent claudication or critical limb ischemia. Smoking and diabetes mellitus are the most important risk factors for developing PAD.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23402467     DOI: 10.1016/j.pop.2012.11.001

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  1 in total

1.  AG490 suppresses EPO-mediated activation of JAK2-STAT but enhances blood flow recovery in rats with critical limb ischemia.

Authors:  Han-Tan Chai; Hon-Kan Yip; Cheuk-Kwan Sun; Shu-Yuan Hsu; Steve Leu
Journal:  J Inflamm (Lond)       Date:  2016-06-04       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.